For: | Honda K, Seike M, Murakami K. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis. World J Hepatol 2015; 7(22): 2404-2410 [PMID: 26464756 DOI: 10.4254/wjh.v7.i22.2404] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i22/2404.htm |
Number | Citing Articles |
1 |
Zheng-xin Li, Zhi-min Zhao, Ping Liu, Qing-shan Zheng, Cheng-hai Liu. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial. Chinese Journal of Integrative Medicine 2021; 27(7): 509 doi: 10.1007/s11655-020-3257-6
|
2 |
Ryan Taylor Anderson, Seng Gee Lim, Poonam Mishra, Filip Josephson, Eric Donaldson, Bruce Given, Veronica Miller. Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus. Gastroenterology 2019; 156(3): 529 doi: 10.1053/j.gastro.2018.11.062
|
3 |
Ming‐Tsung Lin, Kuo‐Chin Chang, Chih‐Chi Wang, Sherry Yueh‐Hsia Chiu, Chee‐Chien Yong, Yueh‐Wei Liu, Wei‐Feng Li, Jing‐Houng Wang, Chao‐Cheng Huang, Chang‐Chun Hsiao, Ming‐Hong Tai, Tsung‐Hui Hu. Comparison of serum WFA+‐M2BP, FIB‐4, and APRI for cirrhosis and esophageal varices prediction in hepatoma patients. Advances in Digestive Medicine 2024; doi: 10.1002/aid2.13369
|
4 |
Sammy Saab, Ping-yu Chen, Clara E. Saab, Myron J. Tong. The Management of Hepatitis B in Liver Transplant Recipients. Clinics in Liver Disease 2016; 20(4): 721 doi: 10.1016/j.cld.2016.06.004
|
5 |
Chueh-Ling Liu, Cheng-Kun Wu, Hon-Yi Shi, Wei-Chen Tai, Chih-Ming Liang, Shih-Cheng Yang, Keng-Liang Wu, Yi-Chun Chiu, Seng-Kee Chuah. Medical expenses in treating acute esophageal variceal bleeding. Medicine 2016; 95(28): e4215 doi: 10.1097/MD.0000000000004215
|
6 |
M.‐L. Wang, E.‐Q. Chen, D.‐M. Zhang, L.‐Y. Du, L.‐B. Yan, T.‐Y. Zhou, X.‐Z. Lei, B.‐J. Lei, J.‐J. Lu, J. Liao, H. Tang. Efficacy and safety of three adefovir‐based combination therapies in HBeAg‐positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy. Journal of Viral Hepatitis 2017; 24(S1): 21 doi: 10.1111/jvh.12792
|
7 |
Ahmad Hormati, Maryam Jameshorani, Seyed Saeed Sarkeshikian , Mansureh Molaei, Mahdi Jahangiri, Mohammad Reza Ghadir. Effects of Atorvastatin Alongside Conventional Medical Treatment on Liver Fibrosis and Dysfunction in Patients with Chronic Hepatitis B: A Double-Blinded Clinical Trial. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84656
|
8 |
Aunchalee Jaroenlapnopparat, Maneerat Chayanupatkul, Pisit Tangkijvanich. Novel viral markers and the prediction of off‐treatment relapse in chronic hepatitis B patients: A systematic review. Journal of Gastroenterology and Hepatology 2021; 36(9): 2349 doi: 10.1111/jgh.15516
|
9 |
Yunqi Liu, Ximei Wang, Fuping Xu, Dengren Li, Huimin Yang, Nan Sun, Yu-Chen Fan, Xiangdong Yang. Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China. Journal of Clinical and Translational Hepatology 2022; 10(2): 238 doi: 10.14218/JCTH.2021.00082
|
10 |
|
11 |
Christine Sempoux, Maria Guido, Romil Saxena. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 679 doi: 10.1016/B978-0-323-42873-6.00041-X
|